Related Experiment Video
Updated: Nov 29, 2025

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
Published on: July 21, 2023
Non-invasive fibrosis algorithms are clinically useful for excluding cirrhosis in prisoners living with hepatitis C
Timothy Papaluca1, Anne Craigie1, Lucy McDonald1
1Department of Gastroenterology, St Vincent's Hospital and the University of Melbourne, Melbourne, Australia.
Insights
Hepatitis C (HCV) cirrhosis can be reliably excluded in prisoners using the AST-to-platelet ratio index (APRI) and FIB-4 scores. These non-invasive markers can reduce the need for transient elastography, simplifying HCV care in correctional facilities.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Prison-based Hepatitis C Virus (HCV) treatment is hindered by barriers, including limited access to transient elastography for cirrhosis assessment.
- Non-invasive markers like the AST-to-platelet ratio index (APRI) and FIB-4 scores show promise in excluding cirrhosis in general populations.
Purpose of the Study:
- To evaluate the performance of APRI and FIB-4 scores in identifying cirrhosis among a large cohort of prisoners with HCV infection.
- To assess the potential of these scores to reduce the reliance on transient elastography in this population.
Main Methods:
- Retrospective cohort study of 1007 prisoners with HCV infection.
- Analysis of sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV) of APRI and FIB-4 for cirrhosis, using transient elastography as the reference standard.
- Exploration of age thresholds as a potential trigger for transient elastography.
Main Results:
- APRI (cut-off 1.0) and FIB-4 (cut-off 1.45) demonstrated high NPVs (96.1% and 96.6%, respectively) for cirrhosis.
- Utilizing these scores for triage could decrease the need for transient elastography by 71%.
- Age ≤35 years alone had a NPV of 96.5% for cirrhosis, and in individuals >35 years, APRI alone showed a high NPV (>95%).
Conclusions:
- APRI and FIB-4 scores are effective tools for excluding cirrhosis in the prison population.
- These non-invasive markers can significantly reduce the requirement for transient elastography, streamlining the care pathway for incarcerated individuals with HCV.
Background And Aims:
Prison-based HCV treatment rates remain low due to multiple barriers, including accessing transient elastography for cirrhosis determination. The AST-to-platelet ratio index (APRI) and FIB-4 scores have excellent negative predictive value (NPV) in hospital cohorts to exclude cirrhosis. We investigated their performance in a large cohort of prisoners with HCV infection.
Methods:
This was a retrospective cohort study of participants assessed by a prison-based hepatitis program. The sensitivity, specificity, NPV and positive predictive value (PPV) of APRI and FIB-4 for cirrhosis were then analysed, with transient elastography as the reference standard. The utility of age thresholds as a trigger for transient elastography was also explored.
Results:
Data from 1007 prisoners were included. The median age was 41, 89% were male, and 12% had cirrhosis. An APRI cut-off of 1.0 and FIB-4 cut-off of 1.45 had NPVs for cirrhosis of 96.1% and 96.6%, respectively, and if used to triage prisoners for transient elastography, could reduce the need for this investigation by 71%. The PPVs of APRI and FIB-4 for cirrhosis at these cut-offs were low. Age ≤35 years alone had a NPV for cirrhosis of 96.5%. In those >35 years, the APRI cut-off of 1.0 alone had a high NPV >95%.
Conclusion:
APRI and FIB-4 scores can reliably exclude cirrhosis in prisoners and reduce requirement for transient elastography. This finding will simplify the cascade of care for prisoners living with hepatitis C.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
10:10Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy
Published on: July 20, 2022